ARCHIVES

Biotech Firm Plans Custom Clinical trials In USSR for Drug Firms

This article is from The Cancer Letter archive.

Vol. 15 No. 33 | August 18, 1989

Download PDF Visit The Full Archive

Related Articles

SmithKline Seeks FDA Action Against Homeopathic Smoking-Cessation Gum

March 6, 1998

Phase III Cyramza Trial Meets OS Primary Endpoint

September 26, 2014

In Brief: MD Anderson’s DuBois Named head of Arizona State’s Biodesign Institute

October 5, 2012

Trastuzumab Increases Risks Of Congestive Heart Failure

August 31, 2012

Arthur James, Ohio Founder Of Research Institute, Dead.

October 26, 2001

Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34%

June 28, 2013